Symbol="ITRM"
AssetType="Common Stock"
Name="Iterum Therapeutics PLC"
Description="Iterum Therapeutics plc, a clinical-stage pharmaceutical company, is engaged in the development of anti-infectives for multidrug resistant pathogens in Ireland and the United States. The company is headquartered in Dublin, Ireland."
CIK="1659323"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="BLOCK 2 FLOOR 3, HARCOURT CENTRE, HARCOURT STREET, DUBLIN, IE"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="14798100"
EBITDA="-29762000"
PERatio="None"
PEGRatio="None"
BookValue="1.48"
DividendPerShare="0"
DividendYield="0"
EPS="-4.45"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.277"
ReturnOnEquityTTM="-1.504"
RevenueTTM="0"
GrossProfitTTM="37000"
DilutedEPSTTM="-4.45"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="1"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1349.79"
PriceToBookRatio="0.445"
EVToRevenue="105.22"
EVToEBITDA="0.534"
Beta="1.59"
num_52WeekHigh="4.348"
num_52WeekLow="0.601"
num_50DayMovingAverage="1.129"
num_200DayMovingAverage="1.22"
SharesOutstanding="12980800"
DividendDate="None"
ExDividendDate="None"
symbol="ITRM"
open="1.11"
high="1.12"
low="1.06"
price="1.06"
volume="49131.00"
latest_trading_day="2023-07-24"
previous_close="1.14"
change="-0.08"
change_percent="-7.0175%"
aroon_positive_momentum_days="52"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="59026"
Change_recent_avg="0.01"
Delta_recent_avg="0.08"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="-0.39"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="1132"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0165.jpeg"
image_negative_thumbnail_id_2="517"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0088.jpeg"
image_neutral_thumbnail_id_1="534"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="701"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0007.jpeg"
image_positive_thumbnail_id_2="675"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
